D2 Dopaminergic and 5-HT1A Serotonergic Activity of 2-(1-Naphthyl)ethyl- and 2-(2-Naphthyl)ethyl Amines
Several tertiary 2‐phenylethyl, 2‐(1‐naphthyl)ethyl and 2‐(2‐naphthyl)ethyl amines were synthesized and their binding affinities for dopamine D1, D2 and serotonin 5‐HT1A receptors evaluated in radioligand binding assays. All compounds were inactive in D1 dopamine radioligand binding assay. The 2‐(1‐...
Saved in:
Published in | Archiv der Pharmazie (Weinheim) Vol. 336; no. 11; pp. 514 - 522 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY-VCH Verlag
01.11.2003
WILEY‐VCH Verlag Wiley-VCH |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Several tertiary 2‐phenylethyl, 2‐(1‐naphthyl)ethyl and 2‐(2‐naphthyl)ethyl amines were synthesized and their binding affinities for dopamine D1, D2 and serotonin 5‐HT1A receptors evaluated in radioligand binding assays. All compounds were inactive in D1 dopamine radioligand binding assay. The 2‐(1‐naphthyl)ethyl analogues expressed a low but significant binding affinity for the D2 and moderate one for the 5‐HT1A receptor subtypes. Most of the remaining compounds expressed binding affinity at the 5‐HT1A receptor subtype but were inactive in D2 receptor binding assay. Based on these results and considering the chemical characteristics of the compounds synthesized and evaluated for dopaminergic and serotonergic activity throughout the present study it can be concluded that hydrophobic type of interaction (stacking or edge‐to‐face) plays a significant role in the formation of receptor‐ligand complexes of 2‐(1‐naphthyl)ethyl amines. This structural motive can be applied to design and synthesize new, more potent dopaminergic/serotonergic ligands by slight chemical modifications. |
---|---|
Bibliography: | ArticleID:ARDP200300776 istex:08BCF3E54A3AFC3C7785AF684C768291202E30BC ark:/67375/WNG-W1KF9VP7-N ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0365-6233 1521-4184 |
DOI: | 10.1002/ardp.200300776 |